Clinical Research Directory
Browse clinical research sites, groups, and studies.
Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis
Sponsor: Idoven 1903 S.L.
Summary
CONCERTO is a retrospective, observational, multicentric and single-arm study to perform an external validation of the cloud-based and AI-powered electrocardiogram (ECG) analysis platform, named Willem™, to detect Transthyretin cardiac amyloidosis (ATTR-CA). Thus, this study will assess Willem™ ability to distinguish between truly diagnosed ATTR-CA patients and confirmed non-ATTR-CA patients from ECG data.
Official title: Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis (CONCERTO)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2025-05-27
Completion Date
2026-05
Last Updated
2026-03-16
Healthy Volunteers
No
Conditions
Locations (10)
Northwestern University
Evanston, Illinois, United States
Centre Hospitalier Universitaire de Toulouse
Toulouse, France
Universitätsklinikum Bonn
Bonn, Germany
L'Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola-Malpighi
Bologna, Italy
Careggi University Hospital
Florence, Italy
United Hospitals of Trieste University Hospital
Trieste, Italy
Hospital Universitario Son Llàtzer
Palma de Mallorca, Balearic Islands, Spain
Hospital Universitario Donostia
San Sebastián, Guipúzcoa, Spain
Hospital Universitario Juan Ramón Jiménez
Huelva, Huelva, Spain
Queen Elizabeth University Hospital, Univeisity of Glasgow
Glasgow, United Kingdom